Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+)
Clinical trial NCT06005350 · UNKNOWN
Trial details
- NCT number
- NCT06005350
- Sponsor
- Charite University, Berlin, Germany
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-12-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.